Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ryan Specialty HoldingsRYAN +0.85%81 3-Year EBITDA Growth Rate is 57.70% as of Jun. 2026, which is 128% above its 10-year median of 25.35. GuruFocus rates RYAN with a GF Scoreâ„¢ of 81/100 and a GF Valueâ„¢ of $79.92 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 292 Insurance companies, Ryan Specialty Holdings ranks better than 89.04% on this metric.
During the past 12 months, Ryan Specialty Holdings's average EBITDA Per Share Growth Rate was 21.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 57.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 27.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ryan Specialty Holdings was 57.70% per year. The lowest was 0.20% per year. And the median was 25.35% per year.
Ryan Specialty Holdings (NYSE:RYAN) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Ryan Specialty Holdings 3-Year EBITDA Growth Rate Related Terms
RYAN vs RDN, ESNT, MTG: 3-Year EBITDA Growth Rate Comparison
For the Insurance - Specialty subindustry, Ryan Specialty Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryan Specialty Holdings 3-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Ryan Specialty Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Ryan Specialty Holdings's 3-Year EBITDA Growth Rate falls into.
Ryan Specialty Holdings 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 57.70% mean?
Ryan Specialty Holdings (RYAN) has a 3-Year EBITDA Growth Rate of 57.70% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ryan Specialty Holdings and its competitors. This is 128% above median its historical median of 25.35. Over the past decade, Ryan Specialty Holdings' 3-Year EBITDA Growth Rate has ranged from 0.20 to 57.70. According to the industry distribution chart, Ryan Specialty Holdings ranks #32 out of 292 companies in the Insurance industry, placing it in the top 11%.
Is Ryan Specialty Holdings' 3-Year EBITDA Growth Rate too high?
Ryan Specialty Holdings' current 3-Year EBITDA Growth Rate of 57.70% is 128% above median its 10-year median of 25.35. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 57.70. The Insurance industry median 3-Year EBITDA Growth Rate is 15.85. Ryan Specialty Holdings' value of 57.70% is 264% above this industry median. Based on the distribution chart, Ryan Specialty Holdings ranks #32 out of 292 companies in the Insurance industry, which is in the top quartile — a strong position relative to peers. Overall, Ryan Specialty Holdings has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ryan Specialty Holdings' 3-Year EBITDA Growth Rate compare to RDN and ESNT?
According to the Insurance industry distribution chart, Ryan Specialty Holdings ranks #32 out of 292 companies for 3-Year EBITDA Growth Rate. This places Ryan Specialty Holdings in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 15.85. Ryan Specialty Holdings' value of 57.70% is 264% above this benchmark. Historically, Ryan Specialty Holdings' own 3-Year EBITDA Growth Rate has ranged from 0.20 to 57.70 over the past decade. While the company's 10-year median is 25.35 vs. the industry median of 15.85, Ryan Specialty Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Insurance company?
The median 3-Year EBITDA Growth Rate among Insurance companies is 15.85, based on 292 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ryan Specialty Holdings's current 3-Year EBITDA Growth Rate of 57.70% is 264% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Ryan Specialty Holdings and its competitors. For the Insurance industry, the median 3-Year EBITDA Growth Rate is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryan Specialty Holdings's current 3-Year EBITDA Growth Rate is 57.70%, which is 128% above median its own 10-year median of 25.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryan Specialty Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ryan Specialty Holdings (RYAN) is currently considered Significantly Undervalued. The stock's GF Value™ is $79.92, compared to a current price of $43.87 — trading 45.1% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 57.70%, which is 128% above median its 10-year median of 25.35 and 264% above the Insurance industry median of 15.85. Ryan Specialty Holdings' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Ryan Specialty Holdings (RYAN), the current 3-Year EBITDA Growth Rate is 57.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ryan Specialty Holdings (RYAN) Overvalued in 2026?
Based on GuruFocus' analysis, Ryan Specialty Holdings stock appears to be undervalued.
The current stock price of $43.87 is trading 45.1% below its estimated GF Value™ of $79.92.
GuruFocus considers Ryan Specialty Holdings to be Significantly Undervalued.
Key valuation signals for RYAN:
3-Year EBITDA Growth Rate: 57.70% (128% above median its 10-year median of 25.35)
GF Value™: $79.92 vs. price of $43.87 (45.1% below fair value)
Industry Position: 264% above the Insurance median (#32 of 292)
No single metric tells the full story. See the RYAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ryan Specialty Holdings Inc is an international specialty insurance intermediary providing specialty products, solutions, and services for insurance brokers, agents, and carriers. The company offers wholesale insurance brokerage and delegated underwriting authority products and services, including distribution, underwriting, product development, administration, and risk management. Its expertise spans property, casualty, professional lines, transportation, personal lines, workers compensation, and employee benefits insurance, across traditional insurance and alternative risk solutions. The company operates in the United States and foreign markets, with the majority of revenue generated from the United States.
81GF Score
Get the complete analysis for RYAN
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYAN has been successfully added to your 
